Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma
- 30 June 1992
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 45 (3) , 284-289
- https://doi.org/10.1016/0090-8258(92)90305-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-hodgkin's lymphomaCancer, 1991
- Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.Journal of Clinical Oncology, 1990
- Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1989
- Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemiaCancer, 1986
- VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.Journal of Clinical Oncology, 1986
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- The Role of Maintenance Therapy in Disseminated Testicular CancerNew England Journal of Medicine, 1981
- The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky memorial lectureCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958